Acute myeloid leukemia (AML) is the most common form of leukemia affecting the blood and bone marrow, and has been responsible for 1.8% of cancer deaths in 2016. Because it is so prevalent, many research teams around the world study this disease in search of new treatment methods. One of these research teams, from Harvard University, has joined up with the pharmaceutical company Merck in a $20 million collaboration to develop new therapeutics for leukemia.Read More
Science Market Update
Six teams of researchers from leading univerisites are going to receive a set of three-year grants, totaling over $7.5 million, to create lab-grown brain cells in a process called neuronal maturation.
The funding to the various universities was made possible by The Paul G. Allen Family Foundation as part of its Allen Distinguished Investigator grants, and will ensure the continued development of important neuroscience research.Read More
Tags: CA, Harvard University, Washington, Parkinson's Disease Research, California, brain research, 2015, Alzheimer' Research, LAVS, Neuroscience, BioResearch Product Faire Event, Research Funding, Harvard, UCSF, longwood, Biotechnology Vendor Showcase Event, best lab supply tradeshows, best science tradeshows